{
  "Factual_Basis_of_Case": {
    "extracted": [
      {
        "evidence": [
          {
            "location": "Page 3",
            "source_document": "Complaint",
            "text": "Average concentrations of airborne chloroprene near the Facility have been consistently greater than 0.2 \u00b5g/m3 since at least 2016, and likely for years before then."
          }
        ],
        "value": "Denka's neoprene manufacturing operations at the Pontchartrain Works Site in St. John the Baptist Parish, Louisiana emit chloroprene at levels exceeding 0.2 \u00b5g/m3, causing unacceptably high cancer risks in surrounding communities"
      },
      {
        "evidence": [
          {
            "location": "Page 15",
            "source_document": "Complaint",
            "text": "The Western monitor, which is closest to the residential neighborhood west of the Facility, showed average concentrations of 2.89 \u00b5g/m3, more than 14 times higher than 0.2 \u00b5g/m3."
          },
          {
            "location": "Page 17",
            "source_document": "Complaint",
            "text": "The Chad Baker site, in the residential neighborhood west of the Facility, showed average concentrations of 2.22 \u00b5g/m3, more than 11 times higher than 0.2 \u00b5g/m3."
          }
        ],
        "value": "Air monitoring data shows average chloroprene concentrations at Denka's Western monitor (2.89 \u00b5g/m3) and Chad Baker site (2.22 \u00b5g/m3) are more than 14 times and 11 times higher than the 0.2 \u00b5g/m3 threshold"
      },
      {
        "evidence": [
          {
            "location": "Page 5",
            "source_document": "Complaint",
            "text": "Infants and children younger than 16 are likely to be especially susceptible to chloroprene's cancer-causing effects. Chloroprene exposure during a person's early years is therefore particularly significant to their lifetime risk of developing cancer."
          },
          {
            "location": "Page 5",
            "source_document": "Complaint",
            "text": "Infants born today in the communities surrounding the Facility who are exposed to the highest measured levels of chloroprene from Denka's neoprene manufacturing operations will exceed an estimated lifetime of acceptable excess cancer risk within approximately their first two years of life."
          }
        ],
        "value": "Infants and children under 16 are especially susceptible to chloroprene's cancer-causing effects, with lifetime cancer risk exceeding 1-in-10,000 within approximately two years of exposure"
      },
      {
        "evidence": [
          {
            "location": "Page 9",
            "source_document": "Complaint",
            "text": "Denka purchased the neoprene manufacturing operations at the Facility in 2014 from E.I. DuPont de Nemours and Company. E.I. DuPont de Nemours and Company (or a predecessor-in-interest) owned and operated the original neoprene manufacturing operations at the Facility from about 1968 until the sale to Denka."
          },
          {
            "location": "Page 17",
            "source_document": "Complaint",
            "text": "Historical sampling, emission data, and air modeling show that, before April 2018 and during the decades when the Facility was owned and operated by E.I. DuPont de Nemours and Company (and its predecessors in interest), people living near the Facility were exposed to chloroprene at average concentrations multiples higher than current levels. Until recently, the neoprene manufacturing operations often emitted more than one hundred tons of chloroprene each year."
          }
        ],
        "value": "Denka's facility has operated since 1968 (originally owned by E.I. DuPont de Nemours), with chloroprene emissions historically exceeding current levels (over 100 tons annually before 2018)"
      },
      {
        "evidence": [
          {
            "location": "Page 6",
            "source_document": "Complaint",
            "text": "A 1-in-10,000 cancer risk is a generally accepted threshold for demarcating the ceiling for acceptable excess cancer risk, and it is a benchmark for the level of cancer risk that is considered important to address in most instances by regulatory agencies."
          },
          {
            "location": "Page 5",
            "source_document": "Complaint",
            "text": "At the average chloroprene concentrations currently being detected, people are being exposed to risks of developing chloroprene-related cancers that are as much as an order of magnitude greater than multiple federal agencies' presumptive benchmark for acceptable excess lifetime cancer risk."
          }
        ],
        "value": "EPA's 1-in-10,000 cancer risk threshold is used as the benchmark for acceptable excess cancer risk, with current emissions causing risks multiple times higher than this standard"
      }
    ],
    "key": "Factual_Basis_of_Case",
    "last_updated": "2025-10-21T00:32:26.264274-04:00"
  }
}